Q-Line Biotech (NSE:QLINE) Accounts Payable: ₹556 Mil (As of Mar. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:QLINE Q-Line Biotech Ltd NSE:QLINE
14 GF Score
Price ₹531.80
! 2 Warning Signs
View Full Analysis

What is Q-Line Biotech Accounts Payable?

Q-Line Biotech NSE:QLINE -1.12% 14 Accounts Payable is ₹556 Mil as of Mar. 2025. GuruFocus rates NSE:QLINE with a GF Score™ of 14/100. The stock has 2 warning signs investors should review.

Q-Line Biotech's Accounts Payable for the quarter that ended in Mar. 2025 was ₹556 Mil.

Q-Line Biotech's quarterly Accounts Payable increased from Mar. 2023 (₹397 Mil) to Mar. 2024 (₹592 Mil) but then declined from Mar. 2024 (₹592 Mil) to Mar. 2025 (₹556 Mil).

Q-Line Biotech's annual Accounts Payable increased from Mar. 2023 (₹397 Mil) to Mar. 2024 (₹592 Mil) but then declined from Mar. 2024 (₹592 Mil) to Mar. 2025 (₹556 Mil).

Q-Line Biotech Accounts Payable Related Terms

Q-Line Biotech Accounts Payable Historical Data

* Premium members only.

The historical data trend for Q-Line Biotech's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Q-Line Biotech Accounts Payable Chart

Q-Line Biotech Annual Data
Trend Mar23 Mar24 Mar25
Accounts Payable
397.06 592.38 556.25

Q-Line Biotech Semi-Annual Data
Mar23 Mar24 Mar25
Accounts Payable 397.06 592.38 556.25
NSE:QLINE
14GF Score
Q-Line Biotech Ltd NSE:QLINE
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Q-Line Biotech Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of ₹556 Mil mean?
Q-Line Biotech (NSE:QLINE) has a Accounts Payable of ₹556 Mil as of Mar. 2025. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Q-Line Biotech and its competitors.
Is Q-Line Biotech's Accounts Payable too high?
Q-Line Biotech's current Accounts Payable is ₹556 Mil. Overall, Q-Line Biotech has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Q-Line Biotech's Accounts Payable compare to ABT and SYK?
Q-Line Biotech's Accounts Payable of ₹556 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Medical Devices & Instruments company?
A good Accounts Payable depends on the Medical Devices & Instruments industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Q-Line Biotech and its competitors. Q-Line Biotech's current Accounts Payable is ₹556 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Q-Line Biotech stock overvalued right now?
Q-Line Biotech (NSE:QLINE) has a current Accounts Payable of ₹556 Mil. The current Accounts Payable is ₹556 Mil. Q-Line Biotech's overall GF Score™ is 14/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Q-Line Biotech (NSE:QLINE), the current Accounts Payable is ₹556 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Q-Line Biotech Business Description

Address Kanpur Road Adjacent Transport Nagar Metro Station, 298-281, Transport Nagar, Lucknow, UP, IND, 226012
Q-Line Biotech Ltd is engaged in the business of developing, manufacturing and marketing of diverse range of reagents (including kits and POC devices) & consumables and manufacturing, importing, distribution/supply of diagnostic equipment for different diagnostic healthcare needs. The company supplies diagnostic equipment and IVD products for different diagnostic healthcare needs directly or through its distributors majorly to diagnostic service providers, hospitals and medical colleges. It is engaged in Manufacturing and Trading into Biochemistry Regnant, Instruments and Consumables. The majority of revenue is derived from the Manufacturing segment.
14GF Score

Get the complete analysis for NSE:QLINE

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹531.80
Price